Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Tenofovir treatment in patients with lamivudine-resistant hepatitis B mutants strongly affects viral replication.

× No keyword cloud information.

18 in total

Review 1. Management of chronic hepatitis B in patients from special populations.

Authors: Ching-Lung Lai; Man-Fung Yuen
Journal: Cold Spring Harb Perspect Med Date: 2015-06-01 Impact factor: 6.915

2. Intracellular metabolism and in vitro activity of tenofovir against hepatitis B virus.

Authors: William E Delaney; Adrian S Ray; Huiling Yang; Xiaoping Qi; Shelly Xiong; Yuao Zhu; Michael D Miller
Journal: Antimicrob Agents Chemother Date: 2006-07 Impact factor: 5.191

Review 3. Chronic hepatitis B--who should be treated?

Authors: Carla S Coffin; Samuel S Lee
Journal: MedGenMed Date: 2006-03-21

4. Tenofovir disoproxil fumarate for the treatment of chronic hepatitis B monoinfection.

Authors: Wai-Kay Seto; Man-Fung Yuen; James Fung; Ching-Lung Lai
Journal: Hepatol Int Date: 2011-06-19 Impact factor: 6.047

5. Combinations of adefovir with nucleoside analogs produce additive antiviral effects against hepatitis B virus in vitro.

Authors: William E Delaney; Huiling Yang; Michael D Miller; Craig S Gibbs; Shelly Xiong
Journal: Antimicrob Agents Chemother Date: 2004-10 Impact factor: 5.191

6. Antiviral effects of lamivudine, emtricitabine, adefovir dipivoxil, and tenofovir disoproxil fumarate administered orally alone and in combination to woodchucks with chronic woodchuck hepatitis virus infection.

Authors: Stephan Menne; Scott D Butler; Andrea L George; Ilia A Tochkov; Yuao Zhu; Shelly Xiong; John L Gerin; Paul J Cote; Bud C Tennant
Journal: Antimicrob Agents Chemother Date: 2008-08-01 Impact factor: 5.191

Tenofovir treatment in patients with lamivudine-resistant hepatitis B mutants strongly affects viral replication.

Review 1. Management of chronic hepatitis B in patients from special populations.

2. Intracellular metabolism and in vitro activity of tenofovir against hepatitis B virus.

Review 3. Chronic hepatitis B--who should be treated?

4. Tenofovir disoproxil fumarate for the treatment of chronic hepatitis B monoinfection.

5. Combinations of adefovir with nucleoside analogs produce additive antiviral effects against hepatitis B virus in vitro.

6. Antiviral effects of lamivudine, emtricitabine, adefovir dipivoxil, and tenofovir disoproxil fumarate administered orally alone and in combination to woodchucks with chronic woodchuck hepatitis virus infection.

Review 7. Management of hepatitis B in patients coinfected with the human immunodeficiency virus.

8. A case of cutaneous reaction with tenofovir disoproxil fumarate.

Review 9. Evaluation and treatment of the patient coinfected with hepatitis B and HIV.

10. Tenofovir and its potential in the treatment of hepatitis B virus.